Audinių atkūrimas

BPC-157 skaičiuoklė

Apskaičiuokite tikslius rekonstitucijos tūrius, insulino vienetus ir dozių skaičių flakone bet kuriam peptidui.

Flakonas, vanduo ir dozė žinomi

BPC-157Ši skaičiuoklė nustatyta peptidui BPC-157

Peptido kiekis (mg)

BAC vanduo (ml)

Dozė (mg)

įprastai 0.2-0.5 mg

mcgmg

Švirkšto dydis

Kalibravimas

U-100U-40

Vienetai = tūris, o ne veiklioji medžiaga

Vienetai matuoja tūrį, o ne veikliąją medžiagą. 10 IU = 0,10 ml. Kiek tame yra mg, priklauso nuo mišinio. Skaičiuoklė tai jau apskaičiavo už Jus.

Beveik visi insulino švirkštai yra U-100. Rinkitės U-40 tik tuo atveju, jei ant švirkšto pažymėta U-40.

Jūsų rezultatas · gyvai

IUmlVienetai

Įtraukite iki

10IU

10 IU / 100 IU (0.100 ml)

Koncentracija

2.50

mg/ml

Tūris vienai dozei

0.100

Dozių skaičius flakone

dozės

už dozę

—

BPC-157

Pagrindiniai duomenys

Dažnumas: daily
Įprastas diapazonas: 0,2-0,5 mg
CAS numeris: 137525-51-0
Molekulinė formulė: C₆₂H₉₈N₁₆O₂₂
Molinė masė: 1 420 g/mol

Sinonimai

PL 14736PL-10BepecinPentadecapeptide BPC 157

Tyrimai ir šaltiniai

Susieti šaltiniai veda į PubMed ir atidaromi naujame skirtuke.

Mokslinis profilis

BPC-157 peptidų leksikone: veikimo mechanizmas, įrodymai ir šaltiniai

→

What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a naturally occurring protective protein found in human gastric juice — BPC (Body Protection Compound) — which plays a role in maintaining the integrity of the gastric mucosal lining. The "157" designation refers to its specific sequence, which was isolated and stabilized for research purposes. Unlike many peptides that are fragile in physiological environments, BPC-157 demonstrates remarkable stability in gastric acid and biological fluids, making it uniquely suited for both oral and parenteral administration in research contexts.

First described in research by the group of Predrag Sikiric at the University of Zagreb in the 1990s, BPC-157 has since accumulated an extensive body of preclinical evidence spanning gastrointestinal healing, musculoskeletal repair, neurological protection, and systemic anti-inflammatory activity. It has been studied in models of tendon and ligament injury, inflammatory bowel disease, traumatic brain injury, peripheral nerve damage, corneal healing, and more. While human clinical trials remain limited, the breadth and consistency of its effects across animal models have made it one of the most discussed peptides in regenerative medicine and performance optimization research.

BPC-157 is not a hormone, does not bind to hormone receptors, and does not suppress the hypothalamic-pituitary axis. Its mechanisms are distinct from GH secretagogues and steroid-based interventions, which contributes to its favorable tolerability profile across a wide range of research applications.

Mechanisms of Action

BPC-157 exerts its biological effects through several distinct and partially overlapping pathways:

Nitric oxide (NO) system modulation: BPC-157 upregulates endothelial nitric oxide synthase (eNOS) and promotes NO-dependent vasodilation and angiogenesis. This vascular effect underpins much of its tissue-healing activity by improving blood supply to injured areas and supporting oxygen and nutrient delivery during repair.
Growth hormone receptor upregulation: BPC-157 increases the expression of growth hormone receptors in tendon fibroblasts and other cells, sensitizing tissues to circulating GH without raising GH levels directly. This mechanism is thought to contribute significantly to its accelerated tendon-to-bone healing effects.
Angiogenesis: Multiple studies demonstrate that BPC-157 promotes the formation of new blood vessels through upregulation of VEGF (vascular endothelial growth factor). Enhanced vascularization accelerates the clearance of metabolic waste and the delivery of growth factors to healing tissue.
Collagen synthesis and fibroblast activity: BPC-157 stimulates fibroblast proliferation and upregulates collagen production, which is essential for restoring structural integrity to tendons, ligaments, and skin. It also modulates the balance between collagen synthesis and degradation by MMPs.
Cytoprotection of the gastrointestinal mucosa: BPC-157 protects the gut lining from damage caused by NSAIDs, alcohol, corticosteroids, and stress-induced ulceration. It accelerates healing of intestinal fistulae, inflammatory bowel lesions, and anastomosis sites. This gastroprotective activity is among its best-characterized properties.
Modulation of dopaminergic and serotonergic systems: Research suggests BPC-157 can normalize neurotransmitter imbalances — particularly in the dopamine and serotonin systems — which may explain observed effects on mood, behavior, and neurological recovery in preclinical models.
Anti-inflammatory activity: BPC-157 suppresses pro-inflammatory cytokines and reduces leukocyte infiltration at injury sites, shortening the inflammatory phase of wound healing without abolishing the immune response.

Dosage Calculation

BPC-157 does not typically require a titration ramp. Most protocols begin directly at the therapeutic dose, though starting at the lower end of the range for the first few days is a reasonable precaution.

Standard Dosing Parameters

Conservative dose: 200 mcg (0.20 mg) per injection
Standard therapeutic dose: 250–300 mcg (0.25–0.30 mg) per injection
Higher range: 400–500 mcg (0.40–0.50 mg) per injection
Frequency: Once daily (some users dose twice daily for active injuries)
Typical syringe: 0.3 mL insulin syringe (29–31 gauge, 6–8 mm needle)

Example Calculation: 5 mg Vial with 2 mL BAC Water

The most common vial size is 5 mg. Adding 2 mL of bacteriostatic water gives a concentration of 2.5 mg/mL (2,500 mcg/mL).

200 mcg dose: 200 ÷ 2500 = 0.08 mL (8 units on a U100 syringe)
250 mcg dose: 250 ÷ 2500 = 0.10 mL (10 units)
300 mcg dose: 300 ÷ 2500 = 0.12 mL (12 units)
500 mcg dose: 500 ÷ 2500 = 0.20 mL (20 units)

At 250 mcg once daily, a 5 mg vial provides 20 days of dosing. Use the BPC-157 calculator above to compute exact volumes for any vial size, reconstitution volume, and target dose.

Injection Site Selection

For systemic effects (gut healing, neurological support, systemic anti-inflammation), subcutaneous injection into the abdomen is the most common and convenient approach. For localized musculoskeletal injuries — such as a torn tendon, ligament sprain, or joint injury — some protocols favor subcutaneous or intramuscular injection at or near the affected tissue. Proximity injection has theoretical advantages based on local concentration gradients but is not strictly required given BPC-157's systemic distribution.

Reconstitution

BPC-157 is supplied as a lyophilized (freeze-dried) powder in sealed vials. It must be reconstituted with bacteriostatic water (BAC water) before use. Do not use sterile water for injection for multi-dose vials — BAC water contains 0.9% benzyl alcohol, which inhibits microbial growth and extends the usable window of the reconstituted solution.

Step-by-Step Reconstitution Protocol

Gather supplies: BPC-157 vial, bacteriostatic water vial, alcohol swabs, a sterile draw needle (18–21 gauge), and your insulin syringe for injection.
Wipe the rubber septa of both vials with fresh alcohol swabs. Allow to air-dry for 30 seconds. Do not blow on the septa or touch them after cleaning.
Draw the desired volume of BAC water (2 mL is standard for a 5 mg vial) into the draw syringe.
Insert the needle into the peptide vial at an angle, directing the tip toward the inner glass wall rather than the lyophilized powder. This is critical: injecting BAC water directly onto the powder cake can shear peptide bonds and denature the molecule.
Slowly push the plunger, allowing BAC water to run down the inside wall of the vial and gradually contact the powder below.
Gently swirl or roll the vial between your palms until the powder is completely dissolved. The solution should appear clear and colorless. Do not shake or vortex the vial.
Label the vial with the reconstitution date and concentration (e.g., "BPC-157 2.5 mg/mL — reconstituted [date]").

If the solution appears cloudy, discolored, or contains visible particulate matter, discard the vial and do not inject it.

Storage and Shelf Life

Lyophilized powder (unreconstituted): Store at −20°C for long-term storage (stable for 24+ months). Short-term storage at 2–8°C (refrigerator) is acceptable for up to 3 months. Keep away from light and moisture. Do not leave at room temperature for extended periods.
Reconstituted solution: Store in the refrigerator at 2–8°C. Stable for approximately 28–30 days. Keep the vial upright and away from light. Write the reconstitution date prominently on the label and discard after 30 days regardless of remaining volume.
Do not freeze reconstituted peptide. Freeze-thaw cycles cause protein aggregation and loss of activity. Once reconstituted, the vial must remain refrigerated throughout its use window.
Transport: Use an insulated cooler with an ice pack for any travel lasting more than 1–2 hours. Commercial insulated medication pouches maintain 2–8°C for 24–48 hours. Avoid exposure to temperatures above 25°C during transport.

Side Effects and Safety Profile

BPC-157 has a consistently favorable safety profile across a large body of preclinical research. It is derived from a naturally occurring gastric protein and has not produced organ toxicity, mutagenicity, or endocrine disruption in animal models even at high doses. That said, human clinical data is limited, and all use remains in the research domain.

Commonly Reported Observations

Mild redness, transient swelling, or brief discomfort at the injection site — resolves within hours in most cases. Rotating injection sites minimizes localized irritation.
Mild nausea, particularly when starting the protocol or if the injection is administered too rapidly. This is more common at higher doses and typically resolves after the first few days.
Temporary dizziness or lightheadedness immediately following injection, likely related to transient NO-mediated vasodilation. Sitting or lying down for a few minutes after injection prevents this in most cases.

Less Common or Theoretical Concerns

Angiogenic effects in the context of existing malignancy: BPC-157 promotes new blood vessel formation, which is generally beneficial for healing but theoretically could support tumor vascularization. Individuals with active malignancies should not use BPC-157 without oncological guidance.
Blood pressure effects: The NO-mediated vasodilatory properties of BPC-157 may theoretically lower blood pressure. Individuals on antihypertensive medications or those with hypotension should monitor carefully.
Interaction with NSAIDs and corticosteroids: While BPC-157 can counteract NSAID-induced gut damage, its interaction with concurrent systemic NSAID or corticosteroid use at the tissue level has not been well characterized.

Contraindications

Active cancer or history of malignancy (without medical supervision)
Pregnancy and breastfeeding (insufficient safety data)
Known hypersensitivity to any component of the preparation

No serious adverse events have been attributed to BPC-157 in the published literature at standard research doses. However, given the absence of large-scale human clinical trials, caution is warranted and consultation with a qualified healthcare provider is strongly recommended.

Combinations and Stacks

BPC-157 + TB-500 — The Healing Stack

The combination of BPC-157 and TB-500 (Thymosin Beta-4) is widely regarded as the most potent dual-peptide healing stack available for musculoskeletal and systemic tissue repair. Often called the Healing Stack, this combination covers complementary repair pathways that neither peptide addresses alone:

BPC-157 drives local angiogenesis, collagen synthesis, and GH receptor upregulation, creating the vascular and structural scaffolding for tissue repair.
TB-500 contributes actin regulation and cell migration — two cellular mechanisms critical for closing wounds and mobilizing repair cells from bone marrow and systemic circulation to the injury site.
Together, they address healing from both the structural and cellular recruitment angles simultaneously, shortening recovery timelines meaningfully in preclinical models.

Typical Healing Stack protocol: BPC-157 250–500 mcg/day + TB-500 2–2.5 mg, 2–3 times per week, both administered subcutaneously, for 4–8 weeks depending on injury severity. View the TB-500 calculator for TB-500 specific dosing guidance.

BPC-157 + GHK-Cu — The Glow Stack

For skin health, anti-aging, and collagen-focused goals, BPC-157 pairs powerfully with GHK-Cu. BPC-157 provides the angiogenic and anti-inflammatory foundation, while GHK-Cu drives collagen synthesis, elastin production, and gene-level tissue renewal. This stack is known at BergdorfBio as the Glow Stack and is particularly popular for skin rejuvenation and recovery from aesthetic procedures.

BPC-157 as a Standalone for Gut Health

BPC-157 is perhaps the most widely researched peptide for gastrointestinal repair. It has demonstrated efficacy in models of NSAID-induced ulceration, inflammatory bowel disease, fistulae, and leaky gut. For gut-specific applications, oral administration may be considered — BPC-157 retains stability in the gastric environment, allowing direct mucosal contact along the GI tract. Research doses for oral use are typically in the 250–500 mcg range, dissolved in water.

You can purchase research-grade BPC-157 directly from BergdorfBio: BPC-157 at BergdorfBio.

Frequently Asked Questions

How quickly does BPC-157 produce noticeable results?

Response speed depends heavily on the application. For acute musculoskeletal injuries, many users report reduced pain and improved mobility within 1–2 weeks of daily dosing. For gastrointestinal issues such as NSAID-related discomfort or gastric inflammation, improvement is often noted within 5–10 days. Structural healing — such as tendon or ligament repair — takes longer to manifest clinically (4–8 weeks minimum) because tissue remodeling is a slow biological process regardless of pharmacological support.

Can BPC-157 be taken orally?

Yes. BPC-157 is unusually stable in the gastric environment due to its derivation from a gastric protein. Oral and sublingual administration are used in research for gut-specific applications. However, oral bioavailability for systemic effects — such as tendon healing or neurological support — is lower than subcutaneous injection. For systemic applications, subcutaneous administration is preferred.

Does BPC-157 need to be injected near the injury site?

Not strictly. Subcutaneous abdominal injection achieves systemic distribution and has demonstrated efficacy for remote injuries in preclinical models. However, some practitioners prefer injecting near the injury site (subcutaneously or intramuscularly) for local concentration advantages, particularly for tendon and ligament injuries. Both approaches appear effective based on available research.

Does BPC-157 affect hormone levels?

No. BPC-157 does not bind to hormone receptors and has no known interaction with the hypothalamic-pituitary-gonadal axis, thyroid function, or adrenal hormones. It upregulates growth hormone receptors at the tissue level without altering systemic GH or IGF-1 concentrations. No post-cycle therapy (PCT) is required.

Is BPC-157 detectable in sports drug testing?

BPC-157 is prohibited under the WADA prohibited list as a peptide hormone and related substance. Standard sports drug tests do not routinely screen for it due to its short half-life and the complexity of detection, but athletes subject to WADA-compliant testing should treat it as prohibited. Always verify the anti-doping rules applicable to your sport and jurisdiction.

How long should a BPC-157 cycle last?

For acute injury recovery, protocols typically run 4–8 weeks continuously, or until the injury resolves. For chronic conditions or general tissue maintenance, 6-week cycles with 2–4 week breaks are common. There is no strong evidence of receptor desensitization with BPC-157, but cycling is recommended out of general precaution given limited long-term human data.

Can BPC-157 and TB-500 be mixed in the same syringe?

While some users do combine them in a single syringe immediately before injection, it is generally safer to use separate syringes. Each peptide should be reconstituted individually, and their combined stability in solution is not well characterized. Separate injections at the same site or adjacent sites add minimal inconvenience while eliminating the risk of peptide interaction or concentration errors.

What is the difference between BPC-157 and BPC-157 arginate salt?

BPC-157 is available in two forms: the free acid form and the arginate salt form (also called BPC-157 stable salt or BPC-157 acetate). The arginate salt has enhanced stability and is better suited for oral administration. Both forms share the same 15-amino-acid core sequence and mechanisms. For subcutaneous injection, both forms are considered equivalent. The acetate/arginate distinction is most relevant when choosing between oral and injectable protocols.

Where can I buy BPC-157?

BergdorfBio offers research-grade BPC-157 with verified purity and concentration. View the product page: BPC-157 bei BergdorfBio kaufen. All products are sold strictly for research purposes.

Medical Disclaimer: The information on this page is provided for educational and research purposes only. BPC-157 is not an approved drug or medical treatment and is sold strictly for research use. Nothing on this page constitutes medical advice, diagnosis, or a recommendation to use any specific compound. Always consult a qualified healthcare professional before beginning any peptide protocol. BergdorfBio assumes no liability for the use or misuse of the information presented here.

Žingsnis po žingsnio

Kaip ištirpinti peptidą

Nuo miltelių iki paruošto švirkšto per penkis žingsnius. Kiekius automatiškai apskaičiuoja aukščiau esanti skaičiuoklė.

011
Paruoškite BAC vandenį
Leiskite flakonui ir vandeniui sušilti iki kambario temperatūros. Nuvalykite abu guminius kamštelius alkoholiu.
022
Įtraukite vandenį
Didesniu švirkštu įtraukite skaičiuoklės rekomenduojamą BAC vandens kiekį.
033
Pilkite lėtai
Leiskite vandeniui tekėti peptido flakono sienele, nepurkškite jo tiesiai ant miltelių.
044
Leiskite ištirpti
Atsargiai pasukite flakoną, nekratykite. Milteliai ištirps ir tirpalas taps skaidrus per 1-2 minutes.
055
Įtraukite dozę
Insulino švirkštu įtraukite tiksliai iki apskaičiuotos žymės. Paruošta.

Nuoroda

Dozės ir flakonų dydžiai pagal peptidą

Įprastos pradinės reikšmės orientacijai. Kiekviena eilutė atidaro to peptido skaičiuoklę.

Peptidas	Kategorija	Įprasta dozė	Flakonų dydžiai	BAC (pradžiai)	Prieinamumas	Skaičiuoti
VIP	Nevropeptidų tyrimai	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Retatrutide	GLP-1/GIP/GCG	0,5-12 mg	2 / 5 / 10 / 15 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Cagrilintide	Amilino analogas	-	5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Semaglutide	GLP-1	0,25-2,4 mg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Tirzepatide	GLP-1/GIP	2,5-15 mg	10 / 15 / 20 / 30 / 60 / 90 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
GHK-Cu	Vario peptidas	1-4 mg	10 / 20 / 50 mg	5 ml	Tik skaičiuoklė	Skaičiuoti
AHK-Cu	Vario peptidas	-	100 mg	5 ml	Tik skaičiuoklė	Skaičiuoti
BPC-157	Audinių atkūrimas	0,2-0,5 mg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
TB-500	Thymosin Beta-4	2-5 mg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
CJC-1295 (be DAC)	GHRH analogas	100-200 mcg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Ipamorelin	GHRP	200-300 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
AOD-9604	Riebalų apykaita	250-500 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
PT-141	Bremelanotide	-	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
MOTS-c	Mitochondrinis	5-10 mg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Selank	Anksiolitinis	150-500 mcg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
SS-31	Elamipretide	0,1-1 mg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Glow Stack	Stack	0,5-2 mg	70 mg	3 ml	Tik skaičiuoklė	Skaičiuoti
Klow Stack	Stack	0,5-2 mg	55 mg	3 ml	Tik skaičiuoklė	Skaičiuoti
Melanotan II	Melanokortinas	100-1000 mcg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Melanotan I	Melanokortinas	-	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Sermorelin	GHRH analogas	50-300 mcg	5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Tesamorelin	GHRH analogas	1-2 mg	10 / 20 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Thymosin Alpha-1	Timuso peptidas	0,8-3,2 mg	1.6 / 5 / 10 mg	1 ml	Tik skaičiuoklė	Skaičiuoti
Epithalon	Ilgaamžiškumas	2-10 mg	10 / 20 / 50 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
KPV	Imuninė sistema / barjeras	100-1000 mcg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
HGH Fragment 176-191	Metabolinis fragmentas	100-500 mcg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Semax	Kognityvinis	100-1000 mcg	10 / 30 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
N-Acetyl Semax	Kognityvinis	100-1000 mcg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Hexarelin	GHRP	50-200 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
GHRP-6	GHRP	50-300 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
GHRP-2	GHRP	50-250 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
DSIP	Miegas	50-500 mcg	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
5-Amino-1MQ	Metabolinis	2,5-10 mg	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Pinealon	Tiriamasis peptidas	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Survodutide	GLP-1/glukagonas	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Kisspeptin-10	KISS1R / GPR54	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
HGH 191AA	Augimo hormonas	1-5 mg	10 mg	1 ml	Tik skaičiuoklė	Skaičiuoti
NAD+	Ilgaamžiškumas / kofaktorius	100-500 mg	1000 mg	10 ml	Tik skaičiuoklė	Skaičiuoti

Reikšmės skirtos orientacijai tyrimų kontekste ir nepakeičia profesionalios konsultacijos.

Kodėl tikslus peptido dozavimas svarbus

Koncentracijos ir injekcijos tūrio apskaičiavimas atrodo paprastas, tačiau tai dažniausia klaidų priežastis. Net 10 % paklaida ištirpinant reiškia, kad veikliosios medžiagos gausite per mažai arba netyčia suleisite per daug.

Liofilizuoti peptidai tiekiami miligramais ir ištirpinami bakteriostatiniame vandenyje (BAC vanduo). Peptido ir vandens santykis lemia koncentraciją, o iš jos išplaukia, kiek vienetų įtrauksite į insulino švirkštą. Insulino švirkštai graduoti vienetais, o ne miligramais. Skaičiuoklė atlieka šį perskaičiavimą ir patikrina patikimumą dėl pavojingiausios klaidos: supainioti mg ir mcg.

DUK

Dažnai užduodami klausimai

Kuo skiriasi mcg ir mg?

Miligramas (mg) yra vienetas, kuriuo parduodami liofilizuoti peptidai, pavyzdžiui, „5 mg BPC-157“. Mikrogramas (mcg) matuoja vienkartinę dozę, pavyzdžiui, „250 mcg vienai injekcijai“. 1 mg = 1 000 mcg. Skaičiuoklė perskaičiuoja automatiškai ir įspėja, jei įvestis atrodo kaip supainioti vienetai.

Ką reiškia „U-100“ ant insulino švirkšto?

U-100 reiškia, kad švirkštas sugraduotas 100 vienetų mililitre. 100 IU = 1 ml, todėl 10 IU = 0,10 ml, nepriklausomai nuo to, kas yra švirkšte. IU skaičiavimas pagrįstas būtent šiuo santykiu.

Kodėl skaičiuoklė kartais rodo labai mažus tūrius?

Kai peptido daug, o vandens mažai, tirpalas tampa labai koncentruotas, todėl vienos dozės tūris būna mažas ir sunkiai nuskaitomas. Naudokitės rekonstitucijos pagalbininku: jis suranda vandens kiekį, kuris duoda aiškią, lengvai nuskaitomą žymę.

Kiek laiko išsilaiko ištirpintas peptidas?

Šaldytuve 2-8 °C temperatūroje paprastai 21-30 dienų. Pažymėkite ant flakono rekonstitucijos datą. Drumstas tirpalas ar dalelės netinka.

Kaip skaičiuoklė veikia su mišiniais, pavyzdžiui, Glow Stack?

Mišiniuose viename flakone yra kelios veikliosios medžiagos. Tiesiog pasirinkite mišinį kaip peptidą: skaičiuoklė papildomai parodys, kiek kiekvieno komponento yra Jūsų injekcijoje. Jei norite derinti kelis atskirus flakonus, naudokitės stackų kūrėju.

Ar skaičiuoklę reikia pildyti kaskart iš naujo?

Ne. Paskutiniai nustatymai saugomi šioje naršyklėje ir atkuriami kitą kartą. Skaičiavimus galite atkurti ir iš istorijos, išsaugoti kaip protokolą arba bendrinti nuoroda.

Susiję peptidai

TB-500Thymosin Beta-4 GHK-CuVario peptidas KPVImuninė sistema / barjeras

Visos skaičiuoklės

Pasirinkite peptidą

Pasirinkite peptidą, kad atidarytumėte jo skaičiuoklės puslapį su iš anksto užpildytomis reikšmėmis.

BPC-157 skaičiuoklė

Pagrindiniai duomenys

Tyrimai ir šaltiniai

What Is BPC-157?

Mechanisms of Action

Dosage Calculation

Standard Dosing Parameters

Example Calculation: 5 mg Vial with 2 mL BAC Water

Injection Site Selection

Reconstitution

Step-by-Step Reconstitution Protocol

Storage and Shelf Life

Side Effects and Safety Profile

Commonly Reported Observations

Less Common or Theoretical Concerns

Contraindications

Combinations and Stacks

BPC-157 + TB-500 — The Healing Stack

BPC-157 + GHK-Cu — The Glow Stack

BPC-157 as a Standalone for Gut Health

Frequently Asked Questions

How quickly does BPC-157 produce noticeable results?

Can BPC-157 be taken orally?

Does BPC-157 need to be injected near the injury site?

Does BPC-157 affect hormone levels?

Is BPC-157 detectable in sports drug testing?

How long should a BPC-157 cycle last?

Can BPC-157 and TB-500 be mixed in the same syringe?

What is the difference between BPC-157 and BPC-157 arginate salt?

Where can I buy BPC-157?

Kaip ištirpinti peptidą

Paruoškite BAC vandenį

Įtraukite vandenį

Pilkite lėtai

Leiskite ištirpti

Įtraukite dozę

Dozės ir flakonų dydžiai pagal peptidą

Kodėl tikslus peptido dozavimas svarbus

Dažnai užduodami klausimai

Susiję peptidai

Pasirinkite peptidą

VIP

Retatrutide

Cagrilintide

Semaglutide

Tirzepatide

GHK-Cu

AHK-Cu

TB-500

CJC-1295 (be DAC)

Ipamorelin

AOD-9604

PT-141

MOTS-c

Selank

SS-31

Glow Stack

Klow Stack

Melanotan II

Melanotan I

Sermorelin

Tesamorelin

Thymosin Alpha-1

Epithalon

KPV

HGH Fragment 176-191

Semax

N-Acetyl Semax

Hexarelin

GHRP-6

GHRP-2

DSIP

5-Amino-1MQ

Pinealon

Survodutide

Kisspeptin-10

HGH 191AA

NAD+

BPC-157 skaičiuoklė

Pagrindiniai duomenys